A detailed history of Kerusso Capital Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Kerusso Capital Management LLC holds 34,333 shares of GILD stock, worth $3.1 Million. This represents 1.83% of its overall portfolio holdings.

Number of Shares
34,333
Previous 32,265 6.41%
Holding current value
$3.1 Million
Previous $2.21 Billion 30.03%
% of portfolio
1.83%
Previous 1.61%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$66.59 - $83.99 $137,708 - $173,691
2,068 Added 6.41%
34,333 $2.88 Billion
Q2 2024

Aug 06, 2024

BUY
$63.15 - $72.88 $2.04 Million - $2.35 Million
32,265 New
32,265 $2.21 Billion

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Kerusso Capital Management LLC Portfolio

Follow Kerusso Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kerusso Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kerusso Capital Management LLC with notifications on news.